EXHIBIT 11
DURA PHARMACEUTICALS, INC.
STATEMENTS RE COMPUTATIONS OF NET INCOME PER SHARE
THREE MONTHS ENDED
MARCH 31,
---------------------------
1996 1997
------------ ------------
PRIMARY NET INCOME PER SHARE: (unaudited)
Net Income . . . . . . . . . . . . . . . . . . $ 4,056,669 $ 8,786,698
------------ ------------
------------ ------------
Weighted Average Number of Common and Common
Equivalent Shares:
Common stock . . . . . . . . . . . . . . . . 31,376,316 43,351,112
Stock options. . . . . . . . . . . . . . . . 1,932,038 1,174,639
Warrants . . . . . . . . . . . . . . . . . . 2,391,264 2,714,066
------------ ------------
Total . . . . . . . . . . . . . . . . . . 35,699,618 47,239,817
------------ ------------
------------ ------------
Net Income per Share . . . . . . . . . . . . . $ 0.11 $ 0.19
------------ ------------
------------ ------------
FULLY DILUTED NET INCOME PER SHARE:
Net Income . . . . . . . . . . . . . . . . . . $ 4,056,669 $ 8,786,698
------------ ------------
------------ ------------
Weighted Average Number of Common and Common
Equivalent Shares Assuming Issuance of All
Dilutive Contingent Shares:
Common stock . . . . . . . . . . . . . . . . 31,376,316 43,351,112
Stock options. . . . . . . . . . . . . . . . 2,089,796 1,174,028
Warrants . . . . . . . . . . . . . . . . . . 2,459,278 2,713,828
------------ ------------
Total . . . . . . . . . . . . . . . . . . 35,925,390 47,238,968
------------ ------------
------------ ------------
Net Income per Share . . . . . . . . . . . . . $ 0.11 $ 0.19
------------ ------------
------------ ------------